|
Organizational Chart
Departmental Flow Chart
Executive Committee
Advisory Board
EXECUTIVE COMMITTEE
The CBB Executive Committee is composed of representatives from eight university departments. It is the primary policy-making group of the CBB and meets regularly to discuss and advise on budgets as well as research and educational programs. CBB members in their respective departments elect representatives of the Executive Committee annually and they may serve a three-year period or more.
| Amnon Kohen, Ph.D. |
Chemistry |
| Tim Mattes, Ph.D. |
Civil & Environmental Engineering |
| Tonya Peeples, Ph.D. |
Chemical & Biochemical Engineering |
| Shahram Khademi, Ph.D. |
Biochemistry |
| Kevin Rice, Ph.D. |
Medicinal & Natural Products Chemistry |
| Chi-Lien Cheng, Ph.D. |
Biological Sciences |
| Alex Horswell, Ph.D. |
Microbiology |
| Mani Subramanian, Ph.D. |
Chemical & Biochemical Engineering
Center for Biocatalysis & Bioprocessing
|
Back
to Top
ADVISORY BOARD
The CBB external Advisory Board consists of distinguished academic and industrial
scientists representing agrochemical, pharmaceutical, chemical and biocatalyst
provider industries. Board members attend the annual CBB conference to discuss
the direction of the Center and its programs, and to offer insights into ways
the Center can best interact with industries through technology transfer. Board
members also provide direction for topics at the annual conference and sometimes
serve as speakers.
| Thomas Binder |
President, ADM Research Division Archer Daniel Midland Company |
| Douglas Cameron |
Chief Scientist, Biotechnology Development Center, Cargill Inc. |
| Ellen L. McCormick |
Director, Pfizer Global Biologics |
| Ramesh N. Patel |
Process Research and Development, Bristol Myers Squibb |
| Dr. Mickey Wells |
Director, Pharmaceutical Service, The University of Iowa |
| Dr. Tim Tressel |
Director, Process and Analytical Sciences, Amgen, Inc. |
Dr. Debbie Yaver
|
Senior Research Manager, Novozymes, Inc. |
| Arnold Demain |
Charles A Dana Research Institute,
Drew University, National Academy of SciencesMember |
| Robert DiCosimo |
Senior Research Fellow,
DuPont Central Research and Development |
| Randolph Greasham |
Director of Process Research,
Merck |
| Steven J. Gould |
Chief Scientific Officer, Mera Pharmaceuticals |
| T. Kent Kirk |
Forest Products Fed Res. Labs,
Dept Bacteriology, University of Wisconsin, Madison, Member
National Academy of Sciences |
| Hans Leuenberger |
Deputy Director, Central
Research, Hoffmann LaRoche |
| Ashwin Madia |
Vice President for Biotechnology
research, Cargill |
| Barry Marrs |
Director of Biotechnology,
Hercules |
| Saul Neidleman |
Neidleman Consulting |
| Peder Holk Nielsen |
Corporate Vice president
for Enzyme Development & Industrial Biotechnology, Novo
Nordisk |
| Nancy Platt |
Vice President for Research, Pioneer
HiBred |
| Rolland Poust |
Director, Pharmaceutical Service, The University of Iowa |
| Karl Sanford |
Vice President for Technology Development, Genencor International |
| Jim Spain |
Air Force Research Laboratory, MLQL, Tyndall Airforce Base |
| Mani Subramanian |
Director, Biotechnology Division, the Dow Chemical Company |
| Susan Truesdell |
Central Research and Development, Pfizer Inc. |
| James F White |
Senior Research Associate, Engelhard
Corporation |
| Gregg Whited |
Genencor International |
| Vincent Witterholt |
Fellow and Distinguished Scientist,
DuPont |
| Milton Zmijewski |
Head, Biocatalysis
Research, Eli Lilly |
Back
to Top
|
